Abintus Bio has a total of 20 patents globally, out of which 1 has been granted. Of these 20 patents, more than 95% patents are active.The United States of America seems to be the main focused R&D center and also the origin country of Abintus Bio.
Abintus Bio was founded in the year 2020. Abintus Bio is a preclinical stage gene therapy company that engages in the field of in vivo immune cell reprogramming. The company’s goal is to improve patient outcomes and access by developing products that manipulate immune cells in their natural habitat. Its main goal is to find and create a portfolio of best-in-class product candidates that use patented vectors and associated technologies to directly reprogrammed immune cells in their natural environments.
Do read about some of the most popular patents of Abintus Bio which have been covered by us in this article and also you can find Abintus Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abintus Bio patent portfolio.
How many patents does Abintus Bio have?
Abintus Bio has a total of 20 patents globally. These patents belong to 3 unique patent families. Out of 20 patents, 19 patents are active.
How Many Patents did Abintus Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Abintus Bio Applications Filed | Abintus Bio Patents Granted |
2020 | 8 | – |
2021 | 10 | – |
2022 | 1 | 1 |
How many Abintus Bio patents are Alive/Dead?
Worldwide Patents
How Many Patents did Abintus Bio File in Different Countries?
Countries in which Abintus Bio Filed Patents
Country | Patents |
United States Of America | 2 |
India | 2 |
Australia | 2 |
Canada | 2 |
Singapore | 2 |
China | 2 |
Europe | 2 |
Israel | 2 |
South Africa | 1 |
Brazil | 1 |
Philippines | 1 |
Where are Research Centers of Abintus Bio Patents Located?
List of Abintus Bio Patents
Abintus Bio | Title |
US20230304031A1 | Vectors And Methods For In Vivo Transduction |
US20220090132A1 | Car T Cell Methods And Constructs |
EP4149495A1 | Vectors And Methods For In Vivo Transduction |
EP3906311A4 | Car T Cell Methods And Constructs |
CN115968300A | Vectors And Methods For In Vivo Transduction |
CN113382741A | Car T-Cell Methods And Constructs |
CA3176697A1 | Vectors And Methods For In Vivo Transduction |
CA3125201A1 | Car T Cell Methods And Constructs |
AU2021273253A1 | Vectors And Methods For In Vivo Transduction |
AU2020205000A1 | Car T Cell Methods And Constructs |
IN202217071240A | Vectors And Methods For In Vivo Transduction |
IN202117033063A | Car T Cell Methods And Constructs |
ZA202103899B | Car T Cell Methods And Constructs |
SG11202260106TA | Vectors And Methods For In Vivo Transduction |
IL297514A | Vectors And Methods For In Vivo Transduction |
PH12021551619A1 | Car T Cell Methods And Constructs |
BR112021013180A2 | Pharmaceutical Composition, Non-Replicating Viral Vector, And, Method To Provide Adoptive Cell Therapy |
IL284461A | Car T Cell Methods And Constructs |
SG11202107246TA | Car T Cell Methods And Constructs |
WO2021231505A1 | Vectors And Methods For In Vivo Transduction |
What are Abintus Bio key innovation segments?
What Technologies are Covered by Abintus Bio?
The chart below distributes patents filed by Abintus Bio